Literature DB >> 32266533

High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.

Cristina Fortes1, S Mastroeni2, A Caggiati3, F Passarelli4, F Ricci5, P Michelozzi6.   

Abstract

Factors that are most associated with positive lymph node status in melanoma are Breslow thickness and ulceration. However, there are other factors that have been little explored and could help in the identification of "at risk patients" harbouring occult metastasis. The objective of this study was to determine whether intensity of tumour-infiltrating lymphocytes (TILs) in a cohort study (N = 4133) is an independent predictor of sentinel lymph node (SLN) status in patients with primary cutaneous melanoma. Of the patients with cutaneous melanoma who resulted negative for nodal metastasis, 50.7% had moderate/marked TILs versus 27.7% among those patients who resulted positive for nodal metastasis. In the multivariate analysis, controlling for sex, age, mitotic rate, ulceration and Breslow, high levels of TILs in primary invasive melanoma was associated with a lower risk of developing SLN metastasis (OR 0.46; 95% CI 0.23-0.95, p = 0.037). When the analysis was stratified by sex, the protective effect of moderate/marked TIL remained only for women (OR 0.30; 95% CI 0.10-0.93, p = 0.037) but not for men (OR 0.51; 95% CI 0.19-1.34, p = 0.172). Other independent predictors of negative lymph node were low Breslow thickness (≤ 2.0 mm) and low mitotic rate. Besides predicting a negative lymph node response, TILs were also associated with a decreased risk of 10-year mortality among females with positive lymph node. Our findings suggest that high level of TILs is an independent predictor of negative SLN status among women. Further research is warranted to confirm our findings.

Entities:  

Keywords:  Cutaneous melanoma; Gender; Lymph node; Tumour-infiltrating lymphocytes

Mesh:

Year:  2020        PMID: 32266533     DOI: 10.1007/s00403-020-02067-0

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  11 in total

1.  The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.

Authors:  Andrew J Sinnamon; Cimarron E Sharon; Yun Song; Madalyn G Neuwirth; David E Elder; Xiaowei Xu; Emily Y Chu; Michael E Ming; Douglas L Fraker; Phyllis A Gimotty; Giorgos C Karakousis
Journal:  J Am Acad Dermatol       Date:  2018-03-05       Impact factor: 11.527

2.  Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.

Authors:  Cristina Fortes; Simona Mastroeni; Thomas J Mannooranparampil; Francesca Passarelli; Alba Zappalà; Giorgio Annessi; Claudia Marino; Alessio Caggiati; Nicoletta Russo; Paola Michelozzi
Journal:  Melanoma Res       Date:  2015-08       Impact factor: 3.599

3.  Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.

Authors:  Ulrike Leiter; Rudolf Stadler; Cornelia Mauch; Werner Hohenberger; Norbert Brockmeyer; Carola Berking; Cord Sunderkötter; Martin Kaatz; Klaus-Werner Schulte; Percy Lehmann; Thomas Vogt; Jens Ulrich; Rudolf Herbst; Wolfgang Gehring; Jan-Christoph Simon; Ulrike Keim; Peter Martus; Claus Garbe
Journal:  Lancet Oncol       Date:  2016-05-05       Impact factor: 41.316

4.  Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Authors:  Mark B Faries; John F Thompson; Alistair J Cochran; Robert H Andtbacka; Nicola Mozzillo; Jonathan S Zager; Tiina Jahkola; Tawnya L Bowles; Alessandro Testori; Peter D Beitsch; Harald J Hoekstra; Marc Moncrieff; Christian Ingvar; Michel W J M Wouters; Michael S Sabel; Edward A Levine; Doreen Agnese; Michael Henderson; Reinhard Dummer; Carlo R Rossi; Rogerio I Neves; Steven D Trocha; Frances Wright; David R Byrd; Maurice Matter; Eddy Hsueh; Alastair MacKenzie-Ross; Douglas B Johnson; Patrick Terheyden; Adam C Berger; Tara L Huston; Jeffrey D Wayne; B Mark Smithers; Heather B Neuman; Schlomo Schneebaum; Jeffrey E Gershenwald; Charlotte E Ariyan; Darius C Desai; Lisa Jacobs; Kelly M McMasters; Anja Gesierich; Peter Hersey; Steven D Bines; John M Kane; Richard J Barth; Gregory McKinnon; Jeffrey M Farma; Erwin Schultz; Sergi Vidal-Sicart; Richard A Hoefer; James M Lewis; Randall Scheri; Mark C Kelley; Omgo E Nieweg; R Dirk Noyes; Dave S B Hoon; He-Jing Wang; David A Elashoff; Robert M Elashoff
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

5.  Stratifying SLN incidence in intermediate thickness melanoma patients.

Authors:  James M Chang; Heidi E Kosiorek; Amylou C Dueck; Stanley P L Leong; John T Vetto; Richard L White; Eli Avisar; Vernon K Sondak; Jane L Messina; Jonathan S Zager; Carlos Garberoglio; Mohammed Kashani-Sabet; Barbara A Pockaj
Journal:  Am J Surg       Date:  2017-12-14       Impact factor: 2.565

6.  Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

Authors:  Farhad Azimi; Richard A Scolyer; Pavlina Rumcheva; Marc Moncrieff; Rajmohan Murali; Stanley W McCarthy; Robyn P Saw; John F Thompson
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

7.  Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.

Authors:  Rebecca C Taylor; Ami Patel; Katherine S Panageas; Klaus J Busam; Mary S Brady
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

8.  Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

Authors:  Dale Han; Jonathan S Zager; Yu Shyr; Heidi Chen; Lynne D Berry; Sanjana Iyengar; Mia Djulbegovic; Jaimie L Weber; Suroosh S Marzban; Vernon K Sondak; Jane L Messina; John T Vetto; Richard L White; Barbara Pockaj; Nicola Mozzillo; Kim James Charney; Eli Avisar; Robert Krouse; Mohammed Kashani-Sabet; Stanley P Leong
Journal:  J Clin Oncol       Date:  2013-11-04       Impact factor: 44.544

9.  Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.

Authors:  Andrew N Hanna; Andrew J Sinnamon; Robert E Roses; Rachel R Kelz; David E Elder; Xiaowei Xu; Barbara A Pockaj; Jonathan S Zager; Douglas L Fraker; Giorgos C Karakousis
Journal:  J Am Acad Dermatol       Date:  2018-08-27       Impact factor: 11.527

10.  A gender factor in shaping T-cell immunity to melanoma.

Authors:  Roxana S Dronca; Haidong Dong
Journal:  Front Oncol       Date:  2015-02-02       Impact factor: 6.244

View more
  2 in total

1.  Tumour-infiltrating lymphocyte and histological regression in primary melanoma.

Authors:  Simone Ribero; I Torres-Navarro; R Botella-Estrada
Journal:  Arch Dermatol Res       Date:  2020-05-07       Impact factor: 3.017

2.  Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.

Authors:  Anna Tosi; Lavinia Nardinocchi; Maria Luigia Carbone; Lorena Capriotti; Elena Pagani; Simona Mastroeni; Cristina Fortes; Fernanda Scopelliti; Caterina Cattani; Francesca Passarelli; Antonio Rosato; Stefania D'Atri; Cristina Maria Failla; Andrea Cavani
Journal:  Biomedicines       Date:  2021-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.